Back to top
more

Tema GLP-1, Obesity & Cardiometabolic ETF: (HRTS)

(Delayed Data from NASDAQ) As of Jun 13, 2025 03:58 PM ET

$28.77 USD

28.77
8,053

-0.37 (-1.27%)

Volume: 8,053

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

ETF Quote Details

Previous Close 29.19
Open 28.79
Bid 24.00
Ask 30.25
Day Low-High 28.76-29.13
52wk Low-High 25.32-36.03
Volume 8,053
NAV (month end) 27.60
Premium (+)/Discount (-) (month end)+1.59

Zacks Premium Research for HRTS

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 NA
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

NA
ETF Report

ETF Expense Ratio

Expense Ratio 0.75%
Dividend (Yield) $0.47 (1.63%)
Issuer TEMA

Benchmark for HRTS

----------------------------------------

This ETF is active and does not track a benchmark.

Fund Summary for HRTS

TEMA GLP-1 OBESITY & CARDIOMETABOLIC ETF

The Tema GLP-1, Obesity & Cardiometabolic ETF seeks to provide long-term growth of capital by investing in GLP-1 and weight loss companies leading the fight against obesity and cardiometabolic diseases.